Please try another search
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial. Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue damage; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is based in Haifa, Israel.
Name | Age | Since | Title |
---|---|---|---|
Joseph Rauch | 66 | 2012 | Executive Chairman of the Board |
Shai Meretzki | 54 | 2012 | Founder, CEO, President & Director |
Benjamin Shafir | 73 | 2020 | Independent Non-Executive Director |
Nimrod Rozen | - | - | Member of Scientific Advisory Board |
Yehuda Ullman | - | - | Member of Scientific Advisory Board |
Alon Ariel | 57 | 2020 | Non-Executive Director |
Ephraim Tzur | - | - | Member of Scientific Advisory Board |
Malcolm I. Hoenlein | 79 | - | Member of Business Advisory Board |
Gil Shapira | 64 | 2012 | Non-Executive Director |
Margalit Asaig | 59 | 2020 | Independent Non-Executive Director |
Or Ben Shoshan | - | - | Member of Business Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review